Skip to main content
Top
Published in: Antimicrobial Resistance & Infection Control 1/2024

Open Access 01-12-2024 | Escherichia Coli | Research

Clinically relevant sequence types of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae detected in Finnish wastewater in 2021–2022

Authors: Viivi Heljanko, Olga Tyni, Venla Johansson, Jussa-Pekka Virtanen, Kati Räisänen, Kirsi-Maarit Lehto, Anssi Lipponen, Sami Oikarinen, Tarja Pitkänen, Annamari Heikinheimo, WastPan Study Group

Published in: Antimicrobial Resistance & Infection Control | Issue 1/2024

Login to get access

Abstract

Background

Antimicrobial resistance (AMR) is a critical threat to human health. Escherichia coli and Klebsiella pneumoniae are clinically the most important species associated with AMR and are the most common carbapenemase-producing (CP) Enterobacterales detected in human specimens in Finland. Wastewater surveillance has emerged as a potential approach for population-level surveillance of AMR, as wastewater could offer a reflection from a larger population with one sample and minimal recognized ethical issues. In this study, we investigated the potential of wastewater surveillance to detect CP E. coli and K. pneumoniae strains similar to those detected in human specimens.

Methods

Altogether, 89 composite samples of untreated community wastewater were collected from 10 wastewater treatment plants across Finland in 2021–2022. CP E. coli and K. pneumoniae were isolated using selective culture media and identified using MALDI-TOF MS. Antimicrobial susceptibility testing was performed using disk diffusion test and broth microdilution method, and a subset of isolates was characterized using whole-genome sequencing.

Results

CP E. coli was detected in 26 (29.2%) and K. pneumoniae in 25 (28.1%) samples. Among E. coli, the most common sequence type (ST) was ST410 (n = 7/26, 26.9%), while ST359 (n = 4/25, 16.0%) predominated among K. pneumoniae. Globally successful STs were detected in both E. coli (ST410, ST1284, ST167, and ST405) and K. pneumoniae (ST512, ST101, and ST307). K. pneumoniae carbapenemases (KPC) were the most common carbapenemases in both E. coli (n = 11/26, 42.3%) and K. pneumoniae (n = 13/25, 52.0%), yet also other carbapenemases, such as blaNDM-5, blaOXA-48, and blaOXA-181, were detected. We detected isolates harboring similar ST and enzyme type combinations previously linked to clusters in Finland, such as E. coli ST410 with blaKPC-2 and K. pneumoniae ST512 with blaKPC-3.

Conclusions

Our study highlights the presence of clinically relevant strains of CP E. coli and K. pneumoniae in community wastewater. The results indicate that wastewater surveillance could serve as a monitoring tool for CP Enterobacterales. However, the specificity and sensitivity of the methods should be improved, and technologies, like advanced sequencing methods, should be utilized to distinguish data with public health relevance, harness the full potential of wastewater surveillance, and implement the data in public health surveillance.
Appendix
Available only for authorised users
Literature
2.
go back to reference Murray CJL, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet. 2022;399(10325):629–55.CrossRef Murray CJL, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet. 2022;399(10325):629–55.CrossRef
3.
go back to reference Ikuta KS, Swetschinski LR, Robles Aguilar G, Sharara F, Mestrovic T, Gray AP, et al. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 2022 Nov; Ikuta KS, Swetschinski LR, Robles Aguilar G, Sharara F, Mestrovic T, Gray AP, et al. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 2022 Nov;
4.
go back to reference European Centre for Disease Prevention and Control. Assessing the health burden of infections with antibiotic-resistant bacteria in the EU/EEA, 2016–2020. Stockholm, 2022. Doi: https://doi.org/10.2900/73460. Accessed 1 Sep 2023. European Centre for Disease Prevention and Control. Assessing the health burden of infections with antibiotic-resistant bacteria in the EU/EEA, 2016–2020. Stockholm, 2022. Doi: https://​doi.​org/​10.​2900/​73460. Accessed 1 Sep 2023.
5.
go back to reference Conlan S, Kong HH, Segre JA. Species-Level Analysis of DNA Sequence Data from the NIH Human Microbiome Project. PLoS One. 2012;7(10). Conlan S, Kong HH, Segre JA. Species-Level Analysis of DNA Sequence Data from the NIH Human Microbiome Project. PLoS One. 2012;7(10).
6.
go back to reference Van Elsas JD, Semenov A V., Costa R, Trevors JT. Survival of Escherichia coli in the environment: Fundamental and public health aspects. Vol. 5, ISME J. 2011. Van Elsas JD, Semenov A V., Costa R, Trevors JT. Survival of Escherichia coli in the environment: Fundamental and public health aspects. Vol. 5, ISME J. 2011.
7.
go back to reference Melo-Nascimento AO dos S, Treumann C, Neves C, Andrade E, Andrade AC, Edwards R, et al. Functional characterization of ligninolytic Klebsiella spp. strains associated with soil and freshwater. Arch Microbiol. 2018;200(8). Melo-Nascimento AO dos S, Treumann C, Neves C, Andrade E, Andrade AC, Edwards R, et al. Functional characterization of ligninolytic Klebsiella spp. strains associated with soil and freshwater. Arch Microbiol. 2018;200(8).
8.
go back to reference Tilahun M, Kassa Y, Gedefie A, Ashagire M. Emerging carbapenem-resistant enterobacteriaceae infection, its epidemiology and novel treatment options: A review. Vol. 14, Infection and Drug Resistance. 2021. Tilahun M, Kassa Y, Gedefie A, Ashagire M. Emerging carbapenem-resistant enterobacteriaceae infection, its epidemiology and novel treatment options: A review. Vol. 14, Infection and Drug Resistance. 2021.
9.
go back to reference Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3). Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3).
11.
go back to reference European Centre for Disease Prevention and Control and World Health Organization. Antimicrobial resistance surveillance in Europe 2023 - 2021 data. Stockholm, 2023. Doi: https://doi.org/10.2900/63495. Accessed 25 Sep 2023. European Centre for Disease Prevention and Control and World Health Organization. Antimicrobial resistance surveillance in Europe 2023 - 2021 data. Stockholm, 2023. Doi: https://​doi.​org/​10.​2900/​63495. Accessed 25 Sep 2023.
13.
go back to reference Peirano G, Chen L, Kreiswirth BN, Pitout JDD. Emerging Antimicrobial-Resistant High-Risk Klebsiella pneumoniae Clones ST307 and ST147. Antimicrob Agents Chemother. 2020 Sep 21;64(10). Peirano G, Chen L, Kreiswirth BN, Pitout JDD. Emerging Antimicrobial-Resistant High-Risk Klebsiella pneumoniae Clones ST307 and ST147. Antimicrob Agents Chemother. 2020 Sep 21;64(10).
14.
go back to reference Wyres KL, Holt KE. Klebsiella pneumoniae population genomics and antimicrobial-resistant clones. Trends Microbiol. 2016;24(12):944–56.CrossRefPubMed Wyres KL, Holt KE. Klebsiella pneumoniae population genomics and antimicrobial-resistant clones. Trends Microbiol. 2016;24(12):944–56.CrossRefPubMed
15.
go back to reference Peirano G, Chen L, Nobrega D, Finn TJ, Kreiswirth BN, DeVinney R, et al. Genomic epidemiology of global carbapenemase-producing Escherichia coli, 2015–2017. Emerg Infect Dis. 2022 May;28(5). Peirano G, Chen L, Nobrega D, Finn TJ, Kreiswirth BN, DeVinney R, et al. Genomic epidemiology of global carbapenemase-producing Escherichia coli, 2015–2017. Emerg Infect Dis. 2022 May;28(5).
16.
go back to reference Räisänen K, Lyytikäinen O, Kauranen J, Tarkka E, Forsblom-Helander B, Grönroos JO, et al. Molecular epidemiology of carbapenemase-producing Enterobacterales in Finland, 2012–2018. European Journal of Clinical Microbiology and Infectious Diseases. 2020;39(9). Räisänen K, Lyytikäinen O, Kauranen J, Tarkka E, Forsblom-Helander B, Grönroos JO, et al. Molecular epidemiology of carbapenemase-producing Enterobacterales in Finland, 2012–2018. European Journal of Clinical Microbiology and Infectious Diseases. 2020;39(9).
17.
go back to reference Linkevicius M, Bonnin RA, Alm E, Svartström O, Apfalter P, Hartl R, et al. Rapid cross-border emergence of NDM-5-producing Escherichia coli in the European Union/European Economic Area, 2012 to June 2022. Eurosurveillance. 2023 May 11;28(19). Linkevicius M, Bonnin RA, Alm E, Svartström O, Apfalter P, Hartl R, et al. Rapid cross-border emergence of NDM-5-producing Escherichia coli in the European Union/European Economic Area, 2012 to June 2022. Eurosurveillance. 2023 May 11;28(19).
18.
go back to reference Andrade LN, Curiao T, Ferreira JC, Longo JM, Clímaco EC, Martinez R, et al. Dissemination of bla KPC-2 by the Spread of Klebsiella pneumoniae Clonal Complex 258 Clones (ST258, ST11, ST437) and Plasmids (IncFII, IncN, IncL/M) among Enterobacteriaceae Species in Brazil. Antimicrob Agents Chemother. 2011;55(7):3579–83.CrossRefPubMedPubMedCentral Andrade LN, Curiao T, Ferreira JC, Longo JM, Clímaco EC, Martinez R, et al. Dissemination of bla KPC-2 by the Spread of Klebsiella pneumoniae Clonal Complex 258 Clones (ST258, ST11, ST437) and Plasmids (IncFII, IncN, IncL/M) among Enterobacteriaceae Species in Brazil. Antimicrob Agents Chemother. 2011;55(7):3579–83.CrossRefPubMedPubMedCentral
19.
go back to reference Queenan AM, Bush K. Carbapenemases: the versatile β-lactamases. Vol. 20, Clinical Microbiology Reviews. 2007. Queenan AM, Bush K. Carbapenemases: the versatile β-lactamases. Vol. 20, Clinical Microbiology Reviews. 2007.
20.
go back to reference Logan LK, Weinstein RA. The epidemiology of carbapenem-resistant enterobacteriaceae: the impact and evolution of a global menace. J Infect Dis. 2017;215(1):S28-36.CrossRefPubMedPubMedCentral Logan LK, Weinstein RA. The epidemiology of carbapenem-resistant enterobacteriaceae: the impact and evolution of a global menace. J Infect Dis. 2017;215(1):S28-36.CrossRefPubMedPubMedCentral
21.
go back to reference Laxminarayan R. The overlooked pandemic of antimicrobial resistance. The Lancet. 2022;399(10325):606–7.CrossRef Laxminarayan R. The overlooked pandemic of antimicrobial resistance. The Lancet. 2022;399(10325):606–7.CrossRef
22.
go back to reference Reinthaler FF, Galler H, Feierl G, Haas D, Leitner E, Mascher F, et al. Resistance patterns of Escherichia coli isolated from sewage sludge in comparison with those isolated from human patients in 2000 and 2009. J Water Health. 2013;11(1):13–20.CrossRefPubMed Reinthaler FF, Galler H, Feierl G, Haas D, Leitner E, Mascher F, et al. Resistance patterns of Escherichia coli isolated from sewage sludge in comparison with those isolated from human patients in 2000 and 2009. J Water Health. 2013;11(1):13–20.CrossRefPubMed
23.
go back to reference Chau KK, Barker L, Budgell EP, Vihta KD, Sims N, Kasprzyk-Hordern B, et al. Systematic review of wastewater surveillance of antimicrobial resistance in human populations. Vol. 162, Environment International. 2022. Chau KK, Barker L, Budgell EP, Vihta KD, Sims N, Kasprzyk-Hordern B, et al. Systematic review of wastewater surveillance of antimicrobial resistance in human populations. Vol. 162, Environment International. 2022.
24.
go back to reference Hendriksen RS, Munk P, Njage P, van Bunnik B, McNally L, Lukjancenko O, et al. Global monitoring of antimicrobial resistance based on metagenomics analyses of urban sewage. Nat Commun. 2019;10(1). Hendriksen RS, Munk P, Njage P, van Bunnik B, McNally L, Lukjancenko O, et al. Global monitoring of antimicrobial resistance based on metagenomics analyses of urban sewage. Nat Commun. 2019;10(1).
25.
go back to reference Hultman J, Tamminen M, Pärnänen K, Cairns J, Karkman A, Virta M. Host range of antibiotic resistance genes in wastewater treatment plant influent and effluent. FEMS Microbiol Ecol. 2018 Apr 1;94(4). Hultman J, Tamminen M, Pärnänen K, Cairns J, Karkman A, Virta M. Host range of antibiotic resistance genes in wastewater treatment plant influent and effluent. FEMS Microbiol Ecol. 2018 Apr 1;94(4).
27.
go back to reference Ayobami O, Brinkwirth S, Eckmanns T, Markwart R. Antibiotic resistance in hospital-acquired ESKAPE-E infections in low- and lower-middle-income countries: a systematic review and meta-analysis. Emerg Microbes Infect. 2022;11(1):443–51.CrossRefPubMedPubMedCentral Ayobami O, Brinkwirth S, Eckmanns T, Markwart R. Antibiotic resistance in hospital-acquired ESKAPE-E infections in low- and lower-middle-income countries: a systematic review and meta-analysis. Emerg Microbes Infect. 2022;11(1):443–51.CrossRefPubMedPubMedCentral
30.
go back to reference Jünemann S, Sedlazeck FJ, Prior K, Albersmeier A, John U, Kalinowski J, et al. Updating benchtop sequencing performance comparison. Vol. 31, Nature Biotechnology. 2013. Jünemann S, Sedlazeck FJ, Prior K, Albersmeier A, John U, Kalinowski J, et al. Updating benchtop sequencing performance comparison. Vol. 31, Nature Biotechnology. 2013.
32.
go back to reference Bolger AM, Lohse M, Usadel B. Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30(15). Bolger AM, Lohse M, Usadel B. Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30(15).
33.
go back to reference Souvorov A, Agarwala R, Lipman DJ. SKESA: Strategic k-mer extension for scrupulous assemblies. Genome Biol. 2018;19(1). Souvorov A, Agarwala R, Lipman DJ. SKESA: Strategic k-mer extension for scrupulous assemblies. Genome Biol. 2018;19(1).
34.
go back to reference Feldgarden M, Brover V, Haft DH, Prasad AB, Slotta DJ, Tolstoy I, et al. Validating the AMRFINder tool and resistance gene database by using antimicrobial resistance genotype-phenotype correlations in a collection of isolates. Antimicrob Agents Chemother. 2019;63(11). Feldgarden M, Brover V, Haft DH, Prasad AB, Slotta DJ, Tolstoy I, et al. Validating the AMRFINder tool and resistance gene database by using antimicrobial resistance genotype-phenotype correlations in a collection of isolates. Antimicrob Agents Chemother. 2019;63(11).
35.
go back to reference Becker L, Kaase M, Pfeifer Y, Fuchs S, Reuss A, von Laer A, et al. Genome-based analysis of Carbapenemase-producing Klebsiella pneumoniae isolates from German hospital patients, 2008–2014. Antimicrob Resist Infect Control. 2018;7(1). Becker L, Kaase M, Pfeifer Y, Fuchs S, Reuss A, von Laer A, et al. Genome-based analysis of Carbapenemase-producing Klebsiella pneumoniae isolates from German hospital patients, 2008–2014. Antimicrob Resist Infect Control. 2018;7(1).
36.
go back to reference Zhou Z, Alikhan NF, Mohamed K, Fan Y, Achtman M. The EnteroBase user’s guide, with case studies on Salmonella transmissions, Yersinia pestis phylogeny, and Escherichia core genomic diversity. Genome Res. 2020;30(1):138–52.CrossRefPubMedPubMedCentral Zhou Z, Alikhan NF, Mohamed K, Fan Y, Achtman M. The EnteroBase user’s guide, with case studies on Salmonella transmissions, Yersinia pestis phylogeny, and Escherichia core genomic diversity. Genome Res. 2020;30(1):138–52.CrossRefPubMedPubMedCentral
37.
go back to reference Brisse S, Fevre C, Passet V, Issenhuth-Jeanjean S, Tournebize R, Diancourt L, et al. Virulent clones of Klebsiella pneumoniae: Identification and evolutionary scenario based on genomic and phenotypic characterization. PLoS One. 2009;4(3). Brisse S, Fevre C, Passet V, Issenhuth-Jeanjean S, Tournebize R, Diancourt L, et al. Virulent clones of Klebsiella pneumoniae: Identification and evolutionary scenario based on genomic and phenotypic characterization. PLoS One. 2009;4(3).
38.
go back to reference Diancourt L, Passet V, Verhoef J, Grimont PAD, Brisse S. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol. 2005;43(8). Diancourt L, Passet V, Verhoef J, Grimont PAD, Brisse S. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol. 2005;43(8).
39.
go back to reference Jamin C, de Koster S, van Koeveringe S, de Coninck D, Mensaert K, de Bruyne K, et al. Harmonization of whole-genome sequencing for outbreak surveillance of enterobacteriaceae and enterococci. Microb Genom. 2021;7(7). Jamin C, de Koster S, van Koeveringe S, de Coninck D, Mensaert K, de Bruyne K, et al. Harmonization of whole-genome sequencing for outbreak surveillance of enterobacteriaceae and enterococci. Microb Genom. 2021;7(7).
40.
go back to reference Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–81.CrossRefPubMed Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–81.CrossRefPubMed
41.
go back to reference Bradford PA, Urban C, Mariano N, Projan SJ, Rahal JJ, Bush K. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein. Antimicrob Agents Chemother. 1997;41(3):563–9.CrossRefPubMedPubMedCentral Bradford PA, Urban C, Mariano N, Projan SJ, Rahal JJ, Bush K. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein. Antimicrob Agents Chemother. 1997;41(3):563–9.CrossRefPubMedPubMedCentral
42.
go back to reference Boyd SE, Holmes A, Peck R, Livermore DM, Hope W. OXA-48-Like β-Lactamases: global epidemiology, treatment options, and development pipeline. Antimicrob Agents Chemother. 2022;66(8). Boyd SE, Holmes A, Peck R, Livermore DM, Hope W. OXA-48-Like β-Lactamases: global epidemiology, treatment options, and development pipeline. Antimicrob Agents Chemother. 2022;66(8).
43.
go back to reference Abramova A, Berendonk TU, Bengtsson-Palme J. A global baseline for qPCR-determined antimicrobial resistance gene prevalence across environments. Environ Int. 2023;178: 108084.CrossRefPubMed Abramova A, Berendonk TU, Bengtsson-Palme J. A global baseline for qPCR-determined antimicrobial resistance gene prevalence across environments. Environ Int. 2023;178: 108084.CrossRefPubMed
44.
go back to reference Osterblad M, Kirveskari J, Hakanen AJ, Tissari P, Vaara M, Jalava J. Carbapenemase-producing Enterobacteriaceae in Finland: the first years (2008–11). J Antimicrob Chemother. 2012;67(12):2860–4.CrossRefPubMed Osterblad M, Kirveskari J, Hakanen AJ, Tissari P, Vaara M, Jalava J. Carbapenemase-producing Enterobacteriaceae in Finland: the first years (2008–11). J Antimicrob Chemother. 2012;67(12):2860–4.CrossRefPubMed
45.
go back to reference Majewski P, Wieczorek P, Łapuć I, Ojdana D, Sieńko A, Sacha P, et al. Emergence of a multidrug-resistant Citrobacter freundii ST8 harboring an unusual VIM-4 gene cassette in Poland. Int J Infect Dis. 2017;61. Majewski P, Wieczorek P, Łapuć I, Ojdana D, Sieńko A, Sacha P, et al. Emergence of a multidrug-resistant Citrobacter freundii ST8 harboring an unusual VIM-4 gene cassette in Poland. Int J Infect Dis. 2017;61.
46.
go back to reference Behruznia M, Gordon DM. Molecular and metabolic characteristics of wastewater associated Escherichia coli strains. Environ Microbiol Rep. 2022;14(4):646–54.CrossRefPubMed Behruznia M, Gordon DM. Molecular and metabolic characteristics of wastewater associated Escherichia coli strains. Environ Microbiol Rep. 2022;14(4):646–54.CrossRefPubMed
47.
go back to reference Saguti F, Magnil E, Enache L, Churqui MP, Johansson A, Lumley D, et al. Surveillance of wastewater revealed peaks of SARS-CoV-2 preceding those of hospitalized patients with COVID-19. Water Res. 2021;189: 116620.CrossRefPubMed Saguti F, Magnil E, Enache L, Churqui MP, Johansson A, Lumley D, et al. Surveillance of wastewater revealed peaks of SARS-CoV-2 preceding those of hospitalized patients with COVID-19. Water Res. 2021;189: 116620.CrossRefPubMed
48.
go back to reference Tiwari A, Kurittu P, Al-Mustapha AI, Heljanko V, Johansson V, Thakali O, et al. Wastewater surveillance of antibiotic-resistant bacterial pathogens: a systematic review. Front Microbiol. 2022;15:13. Tiwari A, Kurittu P, Al-Mustapha AI, Heljanko V, Johansson V, Thakali O, et al. Wastewater surveillance of antibiotic-resistant bacterial pathogens: a systematic review. Front Microbiol. 2022;15:13.
49.
go back to reference Haenni M, Beyrouthy R, Lupo A, Châtre P, Madec JY, Bonnet R. Epidemic spread of Escherichia coli ST744 isolates carrying mcr-3 and blaCTX-M-55 in cattle in France. J Antimicrob Chemother. 2018;73(2):533–6.CrossRefPubMed Haenni M, Beyrouthy R, Lupo A, Châtre P, Madec JY, Bonnet R. Epidemic spread of Escherichia coli ST744 isolates carrying mcr-3 and blaCTX-M-55 in cattle in France. J Antimicrob Chemother. 2018;73(2):533–6.CrossRefPubMed
50.
go back to reference Delgado-Blas JF, Ovejero CM, David S, Montero N, Calero-Caceres W, Garcillan-Barcia MP, et al. Population genomics and antimicrobial resistance dynamics of Escherichia coli in wastewater and river environments. Commun Biol. 2021;4(1):457.CrossRefPubMedPubMedCentral Delgado-Blas JF, Ovejero CM, David S, Montero N, Calero-Caceres W, Garcillan-Barcia MP, et al. Population genomics and antimicrobial resistance dynamics of Escherichia coli in wastewater and river environments. Commun Biol. 2021;4(1):457.CrossRefPubMedPubMedCentral
51.
go back to reference Grönthal T, Österblad M, Eklund M, Jalava J, Nykäsenoja S, Pekkanen K, et al. Sharing more than friendship – transmission of NDM-5 ST167 and CTX-M-9 ST69 Escherichia coli between dogs and humans in a family, Finland, 2015. Eurosurveillance. 2018 Jul 5;23(27). Grönthal T, Österblad M, Eklund M, Jalava J, Nykäsenoja S, Pekkanen K, et al. Sharing more than friendship – transmission of NDM-5 ST167 and CTX-M-9 ST69 Escherichia coli between dogs and humans in a family, Finland, 2015. Eurosurveillance. 2018 Jul 5;23(27).
52.
go back to reference Wilder ML, Middleton F, Larsen DA, Du Q, Fenty A, Zeng T, et al. Co-quantification of crAssphage increases confidence in wastewater-based epidemiology for SARS-CoV-2 in low prevalence areas. Water Res X. 2021;11: 100100.CrossRefPubMedPubMedCentral Wilder ML, Middleton F, Larsen DA, Du Q, Fenty A, Zeng T, et al. Co-quantification of crAssphage increases confidence in wastewater-based epidemiology for SARS-CoV-2 in low prevalence areas. Water Res X. 2021;11: 100100.CrossRefPubMedPubMedCentral
53.
go back to reference Jain M, Koren S, Miga KH, Quick J, Rand AC, Sasani TA, et al. Nanopore sequencing and assembly of a human genome with ultra-long reads. Nat Biotechnol. 2018;36(4):338–45.CrossRefPubMedPubMedCentral Jain M, Koren S, Miga KH, Quick J, Rand AC, Sasani TA, et al. Nanopore sequencing and assembly of a human genome with ultra-long reads. Nat Biotechnol. 2018;36(4):338–45.CrossRefPubMedPubMedCentral
54.
go back to reference Belton JM, McCord RP, Gibcus JH, Naumova N, Zhan Y, Dekker J. Hi–C: A comprehensive technique to capture the conformation of genomes. Methods. 2012;58(3):268–76.CrossRefPubMed Belton JM, McCord RP, Gibcus JH, Naumova N, Zhan Y, Dekker J. Hi–C: A comprehensive technique to capture the conformation of genomes. Methods. 2012;58(3):268–76.CrossRefPubMed
55.
go back to reference Arikawa K, Ide K, Kogawa M, Saeki T, Yoda T, Endoh T, et al. Recovery of strain-resolved genomes from human microbiome through an integration framework of single-cell genomics and metagenomics. Microbiome. 2021;9(1):202.CrossRefPubMedPubMedCentral Arikawa K, Ide K, Kogawa M, Saeki T, Yoda T, Endoh T, et al. Recovery of strain-resolved genomes from human microbiome through an integration framework of single-cell genomics and metagenomics. Microbiome. 2021;9(1):202.CrossRefPubMedPubMedCentral
56.
go back to reference Zhang Z, Zhang G, Ju F. Using culture-enriched phenotypic metagenomics for targeted high-throughput monitoring of the clinically important fraction of the β-Lactam resistome. Environ Sci Technol. 2022;56(16):11429–39.CrossRefPubMed Zhang Z, Zhang G, Ju F. Using culture-enriched phenotypic metagenomics for targeted high-throughput monitoring of the clinically important fraction of the β-Lactam resistome. Environ Sci Technol. 2022;56(16):11429–39.CrossRefPubMed
57.
go back to reference Pruden A, Vikesland PJ, Davis BC, de Roda Husman AM. Seizing the moment: now is the time for integrated global surveillance of antimicrobial resistance in wastewater environments. Vol. 64, Current Opinion in Microbiology. 2021. Pruden A, Vikesland PJ, Davis BC, de Roda Husman AM. Seizing the moment: now is the time for integrated global surveillance of antimicrobial resistance in wastewater environments. Vol. 64, Current Opinion in Microbiology. 2021.
Metadata
Title
Clinically relevant sequence types of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae detected in Finnish wastewater in 2021–2022
Authors
Viivi Heljanko
Olga Tyni
Venla Johansson
Jussa-Pekka Virtanen
Kati Räisänen
Kirsi-Maarit Lehto
Anssi Lipponen
Sami Oikarinen
Tarja Pitkänen
Annamari Heikinheimo
WastPan Study Group
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Antimicrobial Resistance & Infection Control / Issue 1/2024
Electronic ISSN: 2047-2994
DOI
https://doi.org/10.1186/s13756-024-01370-z

Other articles of this Issue 1/2024

Antimicrobial Resistance & Infection Control 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.